Foreign cells in polymyositis: Could stem cell transplantation and pregnancy-derived chimerism lead to the same disease?

Current Rheumatology Reports

Volumn 5, Issue 6, 2003, Pages 437-444

  Stevens, Anne M ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Allogeneic Hematopoietic Stem Cell Transplantation; Graft Versus Host Disease; Hematopoietic Stem Cell Transplantation; Human Leukocyte Antigen Class; Myositis

Indexed keywords

ALLOTRANSPLANTATION; CELL MOTION; CHIMERA; COMPARATIVE STUDY; FEMALE; FETOMATERNAL TRANSFUSION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; PATHOLOGY; POLYMYOSITIS; PREGNANCY; PREVALENCE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

CELL MOVEMENT; CHIMERA; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; POLYMYOSITIS; PREGNANCY; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 1542435290     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-003-0054-0     Document Type: Article

References (60)

1. Sullivan KM, Shulman HM, Storb R, et al.: Chronic graftversus- host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981, 57:267–276. Although from 1981, this is one of the early reports documentating the iatrogenic GVHD in a large number of patients from the pioneers in HSCT. The authors recognize the similarities between GVHD and autoimmune diseases and report treating GVHD with immunosuppressive medications.
2. Flowers MED, Kansu E, Sullivan KM: Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999, 13:1091–1112. This is a valuable update on the current state of knowledge on the risk factors, prognosis, possible mechanisms of disease, and treatment of GVHD. DOI: 10.1016/S0889-8588(05)70111-8
3. Atkinson K, Farrell C, Chapman G, et al.: Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 1986, 63:231–239. DOI: 10.1111/j.1365-2141.1986.tb05545.x
4. Atkinson K, Horowitz MM, Gale RP, et al.: Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990, 75:2459–2464.
5. Flowers ME, Pepe MS, Longton G, et al.: Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br J Haematol 1990, 74:492–496.
6. Kollman C, Howe CW, Anasetti C, et al.: Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001, 98:2043–2051. DOI: 10.1182/blood.V98.7.2043
7. Dalakas MC: Polymyositis, dermatomyositis and inclusionbody myositis. N Engl J Med 1991, 325:1487–1498. DOI: 10.1056/NEJM199111213252107
8. Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344–347. DOI: 10.1056/NEJM197502132920706
9. Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292:403–407. DOI: 10.1056/NEJM197502202920807
10. Anderson BA, Young PV, Kean WF, et al.: Polymyositis in chronic graft versus host disease: a case report. Arch Neurol 1982, 39:188–190.
11. Reyes MG, Noronha P, Thomas W, Jr., Heredia R: Myositis of chronic graft versus host disease. Neurology 1983, 33:1222–1224.
12. Pier N, Dubowitz V: Chronic graft versus host disease presenting with polymyositis. BMJ 1983, 286:2024. DOI: 10.1136/bmj.286.6383.2024
13. Urbano-Marquez A, Estruch R, Grau JM, et al.: Inflammatory myopathy associated with chronic graft-versus-host disease. Neurology 1986, 36:1091–1093.
14. Schmidley JW, Galloway P: Polymyositis following autologous bone marrow transplantation in Hodgkin’s disease. Neurology 1990, 40:1003–1004.
15. Prussick R, Brain MC, Walker IR, Sauder DN: Polymyositis: a manifestation of chronic graft-versus-host disease. J Am Acad Dermatol 1991, 25:560–562.
16. Ascensao JL, Mascarenhas RB, Mittelman A, Ahmed T: Case report: acute polymyositis in a patient with chronic graft vs host disease. Med Oncol Tumor Pharmacother 1992, 9:149–150.
17. Hanslik T, Jaccard A, Guillon JM, et al.: Polymyositis and chronic graft-versus-host disease: efficacy of intravenous gammaglobulin. J Am Acad Dermatol 1993, 28:492–493.
18. Blanche P, Dreyfus F, Sicard D: Polymyositis and chronic graftversus- host disease: efficacy of intravenous gammaglobulin and methotrexate. Clin Exp Rheumatol 1995, 13:377–379.
19. Tse S, Saunders EF, Silverman E, et al.: Myasthenia gravis and polymyositis as manifestations of chronic graft-versushost- disease. Bone Marrow Transplant 1999, 23:397–399. DOI: 10.1038/sj.bmt.1701575
20. Takahashi K, Kashihara K, Shinagawa K, et al.: Myositis as a manifestation of chronic graft-versus-host disease. Intern Med 2000, 39:482–485.
21. Leano AM, Miller K, White AC: Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant. Bone Marrow Transplant 2000, 26:1117–1120. DOI: 10.1038/sj.bmt.1702688
22. Silberstein L, Davies A, Kelsey S, et al.: Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion. Bone Marrow Transplant 2001, 27:231–233. DOI: 10.1038/sj.bmt.1702775
23. Stephenson AL, Mackenzie IR, Levy RD, Road J: Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax 2001, 56:82–84. DOI: 10.1136/thorax.56.1.82
24. George B, Danda D, Chandy M, et al.: Polymyositis: an unusual manifestation of chronic graft-versus-host disease. Rheumatol Int 2001, 20:169–170. DOI: 10.1007/s002960000091
25. Sato N, Okamoto S, Mori T, et al.: Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia. Hematology 2002, 7:109–112. DOI: 10.1080/10245330290022115
26. Kojima K, Kurokawa MS, Tanimoto K, et al.: Clonal expansion of limited T cell clonotypes in affected muscle from a patient with post-transplant polymyositis. Bone Marrow Transplant 2002, 30:467–470. DOI: 10.1038/sj.bmt.1703665
27. Adams C, August CS, Maguire H, Sladky JT: Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 1995, 12:58–61. DOI: 10.1016/0887-8994(94)00097-L
28. Couriel DR, Beguelin GZ, Giralt S, et al.: Chronic graftversus- host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant 2002, 30:543–546. DOI: 10.1038/sj.bmt.1703711
29. Parker P, Chao NJ, Ben-Ezra J, et al.: Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine (Baltimore) 1996, 75:279–285. This report is the first case series of patients with GVHD and PM. The similarities between idiopathic PM and GVHD-PM become apparent. DOI: 10.1097/00005792-199609000-00004
30. Stevens AM, Sullivan KM, Nelson JL: Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford) 2003, 42:34–39. DOI: 10.1093/rheumatology/keg025
31. Medsger TAJ, Dawson WNJ, Masi AT: The epidemiology of polymyositis. Am J Med 1970, 48:715–723. DOI: 10.1016/S0002-9343(70)80006-7
32. Oddis CV, Conte CG, Steen VD, Medsger TAJ: Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963–1982. J Rheumatol 1990, 17:1329–1334.
33. Jacobson DL, Gange SJ, Rose NR, Graham NM: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997, 84:223–243. DOI: 10.1006/clin.1997.4412
34. Zaja F, Barillari G, Russo D, et al.: Myasthenia gravis after allogeneic bone marrow transplantation: a case report and a review of the literature. Acta Neurol Scand 1997, 96:256–259. DOI: 10.1111/j.1600-0404.1997.tb00279.x
35. Reyes MG, Noronha P, Thomas W, Jr., Heredia R: Myositis of chronic graft versus host disease. Neurology 1983, 33:1222–1224.
36. Oshima Y, Takahashi S, Nagayama H, et al.: Fatal GVHD demonstrating an involvement of respiratory muscle following donor leukocyte transfusion (DLT). Bone Marrow Transplant 1997, 19:737–740. DOI: 10.1038/sj.bmt.1700731
37. Stephenson AL, Mackenzie IR, Levy RD, Road J: Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax 2001, 56:82–84. DOI: 10.1136/thorax.56.1.82
38. Rouquette-Gally AM, Boyeldieu D, Gluckman E, et al.: Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol 1987, 66:45–47.
39. Quaranta S, Shulman H, Ahmed A, et al.: Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol 1999, 91:106–116. This is a very careful study using updated, well-controlled assays to evaluate autoantibodies in GVHD. DOI: 10.1006/clim.1998.4666
40. Przepiorka D, Smith TL, Folloder J, et al.: Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999, 94:1465–1470.
41. Adams KM, Lambert NC, Heimfeld S, et al.: Male DNA in female donor apheresis and CD34-enriched products. Blood 2003, in press.
42. Gelpi C, Martinez MA, Vidal S, et al.: Autoantibodies to a transfer RNA-associated protein in a murine model of chronic graft versus host disease. J Immunol 1994, 152:1989–1999.
43. Emslie-Smith AM, Arahata K, Engel AG: Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989, 20:224–231. DOI: 10.1016/0046-8177(89)90128-7
44. Kalovidouris AE: The role of cytokines in polymyositis: interferon-gamma induces class II and enhances class I major histocompatibility complex antigen expression on cultured human muscle cells. J Lab Clin Med 1992, 120:244–251.
45. Nagaraju K, Raben N, Loeffler L, et al.: From the cover: conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A 2000, 97:9209–9214. DOI: 10.1073/pnas.97.16.9209
46. Garlepp MJ: Genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1996, 8:514–520. DOI: 10.1097/00002281-199611000-00004
47. Goldstein R, Duvic M, Targoff IN, et al.: HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 1990, 33:1240–1248. DOI: 10.1002/art.1780330826
48. Rider LG, Shamim E, Okada S, et al.: Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum 1999, 42:1285–1290. DOI: 10.1002/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1
49. Love LA, Leff RL, Fraser DD, et al.: A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991, 70:360–374.
50. Ferrari G, Cusella-De AG, Coletta M, et al.: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998, 279:1528–1530. DOI: 10.1126/science.279.5356.1528
51. Gussoni E, Soneoka Y, Strickland CD, et al.: Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999, 401:390–394.
52. Kawada H, Ogawa M: Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle. Blood 2001, 98:2008–2013. DOI: 10.1182/blood.V98.7.2008
53. Gussoni E, Bennett RR, Muskiewicz KR, et al.: Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 2002, 110:807–814. DOI: 10.1172/JCI200216098
54. LaBarge MA, Blau HM: Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 2002, 111:589–601. DOI: 10.1016/S0092-8674(02)01078-4
55. Ferrari G, Cusella-De AG, Coletta M, et al.: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998, 279:1528–1530. DOI: 10.1126/science.279.5356.1528
56. Nelson JL: Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol Med 2002, 8:109–113. This review thoroughly evaluates the hypothesis that fetal and maternal microchimerism may play roles in autoimmunity. The literature is critically reviewed, and mechanisms by which microchimeric cells may interact with the host immune system are proposed. DOI: 10.1016/S1471-4914(01)02269-9
57. Reed A, Picnorell YJ, Harwood A, Kredich D: Chimerism in children with juvenile dermatomyositis. Lancet 2000, 356:2156–2157. DOI: 10.1016/S0140-6736(00)03500-5
58. Artlett CM, Ramos R, Jiminez SA, et al.: Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 2000, 356:2155–2156. DOI: 10.1016/S0140-6736(00)03499-1
59. Lee TH, Reed W, Mangawang-Montalvo L, et al.: Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility. Transfusion 2001, 41:637–642. DOI: 10.1046/j.1537-2995.2001.41050637.x
60. Lee TH, Paglieroni T, Ohto H, et al.: Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999, 93:3127–3139.